| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |